,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2016-05-31 08:15:00,The shorts -- of which there are many -- should be worried.,0.041299015283584595,0.3523402214050293,0.6063607335090637,neutral,-0.3110412061214447
1,2016-05-31 08:15:00,Veeva Systems (NYSE: VEEV) -- the cloud specialist with a niche in the pharmaceutical industry -- reported earnings this week that blew past expectations.,0.48497316241264343,0.4652543365955353,0.04977256432175636,positive,0.019718825817108154
2,2016-05-31 08:15:00,"This has become commonplace, as the company has bested estimates in all 11 quarters as a public company.",0.9239600300788879,0.029314618557691574,0.04672534018754959,positive,0.8946453928947449
3,2016-05-31 08:15:00,"More importantly, results came in ahead of what management had forecasted -- showing that founder/CEO Peter Gassner can generally be trusted not to overstate his company's potential.",0.9024896621704102,0.03043036162853241,0.06707996875047684,positive,0.8720592856407166
4,2016-05-31 08:15:00,"Heading into Thursday evening's earnings release, I outlined what investors should look for in Veeva's two key product offerings: Veeva CRM and Veeva Vault.",0.06708195060491562,0.004891730844974518,0.9280263185501099,neutral,0.0621902197599411
5,2016-05-31 08:15:00,Let's see how results stacked up.,0.10198970139026642,0.007340922951698303,0.8906693458557129,neutral,0.09464877843856812
6,2016-05-31 08:15:00,"CRM continues to add customers and woo them with add-ons

Veeva's customer relationship applications (CRM) are its bread and butter.",0.1396569460630417,0.005903567653149366,0.8544394373893738,neutral,0.13375337421894073
7,2016-05-31 08:15:00,Revenue from the segment has typically brought in more than three quarters of revenue.,0.559195339679718,0.011127361096441746,0.429677277803421,positive,0.5480679869651794
8,2016-05-31 08:15:00,"Heading into the report, I noted investors should look for incremental improvements in total customer count, while hoping for the real boost to come from high-margin add-ons established customers usually buy.",0.937386155128479,0.01929771527647972,0.04331609234213829,positive,0.918088436126709
9,2016-05-31 08:15:00,"Though management didn't provide specifics for either metric in the company's release or conference call, the language surrounding the performance of CRM was encouraging.",0.8612797260284424,0.01663309335708618,0.12208719551563263,positive,0.8446466326713562
10,2016-05-31 08:15:00,"On the customer front, Gassner said , ""we started our first CRM project with another top 20 Pharma.""",0.3875226676464081,0.008104613982141018,0.6043727397918701,neutral,0.3794180452823639
11,2016-05-31 08:15:00,"That alone is cause for celebration, as there were few top 20 pharmaceutical companies not using Veeva's CRM solution.",0.05887267366051674,0.6006453633308411,0.3404819667339325,negative,-0.5417726635932922
12,2016-05-31 08:15:00,"And from an add-ons viewpoint, it's clear there was significant traction in the first quarter.",0.8870797753334045,0.014866248704493046,0.09805396944284439,positive,0.8722135424613953
13,2016-05-31 08:15:00,"Gassner stated, ""Our newest CRM add-on products are starting to gain meaningful traction as well.""",0.9107885956764221,0.013516165316104889,0.07569520175457001,positive,0.8972724080085754
14,2016-05-31 08:15:00,"The company's Events Management, Align, and Approved E-mail applications were singled out as the stars, here.",0.3407413959503174,0.017227912321686745,0.6420307159423828,neutral,0.3235134780406952
15,2016-05-31 08:15:00,"Because these are higher-margin offerings, subscription services saw non-GAAP gross margins expand 100 basis points during the quarter to 79%.",0.9576929807662964,0.01919444277882576,0.023112501949071884,positive,0.9384985566139221
16,2016-05-31 08:15:00,There was a lot of positive news management announced when it came to Vault.,0.294034481048584,0.009420798160135746,0.6965447068214417,neutral,0.2846136689186096
17,2016-05-31 08:15:00,"I was a little disappointed the company didn't provide a breakdown of customers signed up for all of the Vault applications (Clinical, Quality, Regulatory), but again, the discussion surrounding the applications was very positive.",0.19264578819274902,0.026379060000181198,0.7809751629829407,neutral,0.16626672446727753
18,2016-05-31 08:15:00,"The company announced a secondary product offering in Vault Quality: Vault QMS, which ""will be used to manage quality work processes, so the identification of problems in manufacturing, documenting a plan to fix the problems and tracking the implementation of remediation plans.""",0.1193670704960823,0.005238670390099287,0.8753942251205444,neutral,0.11412840336561203
19,2016-05-31 08:15:00,"Gassner noted that the application only took six months to develop in response to customer demand, and that it was able to do so that quickly because of the leverage the Vault platform provided.",0.8274685144424438,0.012132941745221615,0.16039852797985077,positive,0.8153355717658997
20,2016-05-31 08:15:00,He also said Vault QMS would double the total addressable market within Vault Quality.,0.9233548045158386,0.013666100800037384,0.06297912448644638,positive,0.9096887111663818
21,2016-05-31 08:15:00,"In all, the company said it had 11 new regulatory customers -- a 26% jump assuming there was no churn -- and that it had 18 Vault customers total with seven-figure contracts in place.",0.7256481647491455,0.020437465980648994,0.25391441583633423,positive,0.7052106857299805
22,2016-05-31 08:15:00,"But perhaps the most interesting comments from the call came when Gassner said Vault might soon be offering its products outside of the life sciences industry:

This is huge news investors need to keep an eye on.",0.19376355409622192,0.006750546861439943,0.7994858622550964,neutral,0.18701300024986267
23,2016-05-31 08:15:00,"By focusing on other heavily regulated industries, Veeva is massively expanding its total addressable market.",0.8838463425636292,0.01176144927740097,0.1043921634554863,positive,0.87208491563797
24,2016-05-31 08:15:00,"While results from the effort are likely to be small at first, I wouldn't be surprised to see significant traction within the next 12 months.",0.3403107225894928,0.02017952874302864,0.6395097374916077,neutral,0.32013118267059326
25,2016-05-31 08:15:00,"That, combined with a slight guidance bump in full-year revenue and non-GAAP EPS, is what helps explain the company's 10% jump in the market on Friday.",0.9073344469070435,0.03421007841825485,0.05845539644360542,positive,0.873124361038208
26,2016-05-31 08:15:00,"I don't know about you, but I always pay attention when one of the best growth investors in the world gives me a stock tip.",0.18418462574481964,0.016995061188936234,0.7988203167915344,neutral,0.1671895682811737
27,2016-05-31 08:15:00,"Motley Fool co-founder David Gardner (whose growth-stock newsletter was the best performing in the U.S. as reported by The Wall Street Journal )* and his brother, Motley Fool CEO Tom Gardner, just revealed two brand new stock recommendations.",0.3675956726074219,0.028515469282865524,0.6038888692855835,neutral,0.33908021450042725
28,2016-05-31 08:15:00,"Together, they've tripled the stock market's return over the last 13 years.",0.8617573380470276,0.01660022884607315,0.12164242565631866,positive,0.8451570868492126
29,2016-05-31 08:15:00,"And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their ideas.",0.1304788589477539,0.013598263263702393,0.8559228777885437,neutral,0.11688059568405151
30,2016-05-31 08:15:00,Click here to be among the first people to hear about David and Tom's newest stock recommendations.,0.048487842082977295,0.013823814690113068,0.9376883506774902,neutral,0.03466402739286423
31,2016-05-31 08:15:00,"*""Look Who's on Top Now"" appeared in The Wall Street Journal in Aug. 2013, which references Hulbert's rankings of the best-performing stock-picking newsletters over a 5-year period from 2008-2013.",0.43269848823547363,0.025399764999747276,0.541901707649231,neutral,0.4072987139225006
32,2016-05-31 08:15:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
